Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Grand Forks, USA
4201 James Ray Drive REAC 1 Building
Suite 2200
Grand Forks, ND, 58202
USA

People

Chief Executive Officer and Director
Board Member
Scientific Founder and President
Scientific Founder

Funding

TOTAL $34.6M
FUNDING TOTAL $34.6M
Seed, 2/2013
$20.6M
Series B, 10/2013
RusnanoMedInvest
Domain Associates
$14M

Tags

NovaDigm Therapeutics

NovaDigm Therapeutics, Inc. develops vaccines to protect patients from fungal and bacterial infections. Its products include NDV-3, a vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by fungal and bacterial pathogens; and Als3, an antigen vaccine, which provides protection against systemic and mucosal candidal infections. NovaDigm Therapeutics, Inc. was founded in 2005 and is based in Grand Forks, North Dakota.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. NovaDigm Therapeutics Closes $14M Series B Financing (finsmes.com) [edit]
Edit This Page
Last Edited 10/3/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy